Gene: LIMK1
Official Full Name: LIM domain kinase 1provided by HGNC
Gene Summary: There are approximately 40 known eukaryotic LIM proteins, so named for the LIM domains they contain. LIM domains are highly conserved cysteine-rich structures containing 2 zinc fingers. Although zinc fingers usually function by binding to DNA or RNA, the LIM motif probably mediates protein-protein interactions. LIM kinase-1 and LIM kinase-2 belong to a small subfamily with a unique combination of 2 N-terminal LIM motifs and a C-terminal protein kinase domain. LIMK1 is a serine/threonine kinase that regulates actin polymerization via phosphorylation and inactivation of the actin binding factor cofilin. This protein is ubiquitously expressed during development and plays a role in many cellular processes associated with cytoskeletal structure. This protein also stimulates axon growth and may play a role in brain development. LIMK1 hemizygosity is implicated in the impaired visuospatial constructive cognition of Williams syndrome. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Feb 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36829 | LIMK1 Knockout cell line (HeLa) | Human | LIMK1 | 1:3~1:6 | Negative | Online Inquiry |
KO36830 | LIMK1 Knockout cell line (HCT 116) | Human | LIMK1 | 1:2~1:4 | Negative | Online Inquiry |
KO36831 | LIMK1 Knockout cell line (HEK293) | Human | LIMK1 | 1:3~1:6 | Negative | Online Inquiry |
KO36832 | LIMK1 Knockout cell line (A549) | Human | LIMK1 | 1:3~1:4 | Negative | Online Inquiry |
LIMK1 Gene Knockout Cell Lines are genetically engineered cell lines where the LIMK1 gene has been selectively disrupted or knocked out. These cell lines serve as invaluable tools for investigating the biological roles of LIMK1, a serine/threonine kinase that plays a crucial role in regulating actin cytoskeleton dynamics and cell signaling pathways. The knockout of LIMK1 leads to observable changes in cell morphology, migration, and proliferation, enabling researchers to elucidate its function in various physiological and pathological contexts.
The mechanism of action in these knockout cell lines revolves around the loss of LIMK1's ability to phosphorylate cofilin, a critical player in the regulation of actin turnover. By eliminating this phosphorylation, these cell lines allow researchers to study the resulting alterations in actin filament dynamics and cell behavior. This is particularly significant in cancer biology, neurobiology, and developmental studies, as aberrations in LIMK1 activity have been associated with tumor progression and neuronal development.
The scientific importance of LIMK1 Gene Knockout Cell Lines extends to their application in both research and clinical settings. They provide a platform for high-throughput screening of drugs targeting pathways affected by LIMK1 modulation, contributing to the development of therapeutics in cancer and other diseases linked to cytoskeletal abnormalities. Furthermore, they serve as excellent models for studying cellular responses to environmental cues and understanding the mechanisms of cellular motility.
Our LIMK1 Gene Knockout Cell Lines offer several advantages over alternative models, including enhanced specificity due to the targeted knockout method, greater consistency in results, and reduced variability typically seen with conventional cell line models. As a result, researchers can expect more reliable and reproducible data, facilitating the validation of hypotheses around cellular behaviors influenced by LIMK1.
In summary, LIMK1 Gene Knockout Cell Lines represent a powerful resource for researchers and clinicians dedicated to advancing our understanding of cytoskeletal dynamics, tumor biology, and related fields. At [Company Name], we pride ourselves on our commitment to providing high-quality, innovative genetic models that empower scientific discovery and contribute to advancements in biomedical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.